What Sabby Management, LLC reported holding on Form 13F for the quarter ended Jun 30, 2026.
CIK 1535610 · Filed Aug 14, 2026
Values are as the managers reported them, in dollars.Open the Form 13F on SEC EDGAR
| Security | Shares | Change | Value | Of portfolio |
|---|---|---|---|---|
STATE STREET SPDR S&PETFPut option | 725 | +62.2% | $54.1M | 49% |
STATE STREET SPDR S&PETFCall option | 205 | New | $15.3M | 13.9% |
ISHARES RUSSELLETFCall option | 442 | New | $13.3M | 12% |
ISHARES RUSSELL |
| 441 |
| +47.0% |
| $13.2M |
| 12% |
SPYSPDR S&P 500 ETF Trust | 5.5K | +101.2% | $4.1M | 3.7% |
TOYOTOYO Co., Ltd | 503.8K | New | $3.5M | 3.2% |
ABIVAX SAADSCall option | 82 | +6.5% | $1.1M | 1% |
FAMIFarmmi, Inc. | 3.5M | New | $840.3K | 0.8% |
SIDUS SPACE INCCL APut option | 2.9K | New | $816.3K | 0.7% |
CRVOCervoMed Inc. | 248.9K | New | $771.5K | 0.7% |
ZEVRA THERAPEUTICSCOMPut option | 427 | +25.6% | $612.3K | 0.6% |
TPSTTempest Therapeutics, Inc. | 511.3K | +2,763.4% | $567.5K | 0.5% |
PAVSParanovus Entertainment Technology Ltd. | 75.4K | New | $560.5K | 0.5% |
BIAFbioAffinity Technologies, Inc. | 365.6K | New | $296.9K | 0.3% |
CREGSmart Powerr Corp. | 127.8K | New | $263.2K | 0.2% |
BCTXBriaCell Therapeutics Corp. | 80.7K | +9.2% | $261.5K | 0.2% |
REVBRevelation Biosciences, Inc. | 210.6K | +111.8% | $216.9K | 0.2% |
SNESSenesTech, Inc. | 141.8K | −35.1% | $211.2K | 0.2% |
BCTXLBriaCell Therapeutics Corp. | 190.4K | −50.0% | $169.4K | 0.2% |
SIDUSidus Space Inc. | 43.4K | New | $121.9K | 0.1% |
INMInMed Pharmaceuticals Inc. | 45K | −79.6% | $69.7K | 0.1% |
NUWENuwellis, Inc. | 16.4K | New | $49.9K | 0.1% |
BCTXZBriaCell Therapeutics Corp. | 120.8K | −41.6% | $11.5K | 0.1% |